PMC/PubMed Indexed Articles
Indexed In
- Open J Gate
- Academic Keys
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- Geneva Foundation for Medical Education and Research
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
A COMPARATIVE STUDY BETWEEN HYALURONIC ACID AND CORTICOSTEROIDS FOR THE TREATENT OF THE GREATER TROCHANTERIC PAIN SYNDROME
7th World Congress on Healthcare & Technologies
September 26-27, 2016 London, UK
Asuncion Acosta Pereira, Berta Magallares Lopez and Arturo Rodriguez de la Serna
Hospital de la Santa Creu i Sant pau, Spain
Posters & Accepted Abstracts: Health Care: Current Reviews
Abstract:
To date, there are no studies addressing the efficacy of hyaluronic acid (HA) injections at the trochanteric bursa in patients with greater trochanteric pain syndrome (GTPS). The objective of the study was to compare the efficacy and safety of HA to corticosteroid injections for the treatment of the GTPS. Patients received an intra-bursal injection of 40 mg triamcinolone acetonide plus 1 ml lidocaine, or 60 mg HA. Patients completed visual analog scales (VAS) and Likert scales to evaluate interference of pain with daily activity, recovery from pain, and treatment satisfaction. A non-inferiority analysis was performed. Results: Mean VAS score for pain significantly decreased compared baseline with 1, 3 and 6 months in both treatment groups. VAS score for pain on palpation was also significantly lower than baseline in both arms. No significant differences were found between groups. Analisys of Likert scales at the sixth month did not detect statistically significant differences between treatment groups. The non-inferiority analysis showed that the treatment with HA was no inferior to corticosteroids. No secondary adverse effects were found among the patients in both groups during the follow-up. Conclusions: The treatment with HA has demonstrated to be non-inferior to corticosteroids after 6 months of follow-up in patients with GTPS. Therfore, the treatment with HA may be considered an effective alternative therapeutic strategy to reduce pain in patients in whom the treatment with corticosteroids, or other therapies have been unsuccessful or contraindicated.
Biography :
Email: bmagallares@santpau.cat